Dosage and usage guidance for selexipag tablets to ensure safety and effectiveness

Selexipag tablets (Selexipag) is a drug specially used to treat pulmonary arterial hypertension (PAH). Pulmonary hypertension is a serious cardiovascular disease in which the patient's pulmonary artery blood pressure increases abnormally, causing increased burden on the heart. Symptoms such as dyspnea, fatigue, and chest pain may occur, and in severe cases, it may even be life-threatening. Serepag tablets promote the relaxation of pulmonary arteries by activating prostacyclin receptors in the body, thereby improving blood circulation, alleviating symptoms, and delaying disease progression.

In order to ensure the safe and effective use of selepag tablets, patients need to strictly follow the doctor's instructions. First, selepag tablets should be taken orally, and it is recommended to take them with meals to improve tolerability. The drug should be taken once in the morning and once in the evening, and each dose needs to be adjusted according to individual circumstances. The starting dose is usually 0.2 mg twice a day, and then the dose can be gradually increased according to the patient's tolerance and response, but the increase in magnitude and frequency must be strictly in accordance with the doctor's recommendations. The dose is usually increased once a week until the patient's highest tolerated dose is reached. The maximum dose is generally no more than 1.6 mg twice daily.

During use, patients should not break, crush or chew the tablets, but should take the tablets whole with water. For patients with poor vision or blindness, assistance should be provided during dosage adjustments to ensure accuracy.

In addition, treatment with selepag tablets should be monitored and adjusted by a physician experienced in the treatment of pulmonary arterial hypertension. Doctors will determine the most appropriate medication plan based on the patient's specific conditions, such as severity of illness, liver and kidney function, age and other factors.

Patients should pay close attention to their body's reaction during the medication. If any symptoms of discomfort occur, they should seek medical treatment in time and inform the doctor. At the same time, relevant examinations, such as pulmonary function tests, electrocardiograms, etc., are performed regularly to evaluate the efficacy and safety of the drugs.

In short, Serepag tablets are an effective drug for the treatment of pulmonary arterial hypertension, but patients must strictly follow the doctor's instructions when using it to ensure the safety and effectiveness of the drug. Through reasonable medication regimens and close monitoring, patients can better control their condition and improve their quality of life.

Reference link:https://www.drugs.com/mtm/selexipag-oral-injection.html